Charles River Labs (CRL) Tops Q2 EPS by 10c; Boosts FY11 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $345.37 +1.68%
EPS Growth %: +22.2%
Financial Fact:
Net sales related to products: 132.87M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +22.2%
Financial Fact:
Net sales related to products: 132.87M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Charles River Laboratories International, Inc. (NYSE: CRL) reported Q2 EPS of $0.70, ex-items, $0.10 better than the analyst estimate of $0.60. Revenue for the quarter came in at $288.3 million versus the consensus estimate of $287.9 million.
Sees FY2011 EPS of $2.38-$2.48, versus prior guidance of $2.20-$2.40 and the consensus of $2.39.
Sees FY2011 EPS of $2.38-$2.48, versus prior guidance of $2.20-$2.40 and the consensus of $2.39.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Tompkins Financial (TMP) Tops Q3 EPS by 5c
- Rogers Communications (RCI) Tops Q3 EPS by 42c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
